Author:
Li Qi,Zhou Zhenghao,Chen Yukun,Yu Jieyu,Zhang Hao,Meng Yinghao,Zhu Mengmeng,Li Na,Zhou Jian,Liu Fang,Fang Xu,Li Jing,Wang Tiegong,Lu Jianping,Zhang Teng,Xu Jun,Shao Chengwei,Bian Yun
Funder
National Science Foundation for Scientists of China
Natural Science Foundation of Shanghai Science and Technology Innovation Action Plan
Clinical Research Plan of SHDC
234 Platform Discipline Consolidation Foundation Project
Publisher
Springer Science and Business Media LLC
Subject
Urology,Gastroenterology,Radiology, Nuclear Medicine and imaging,Radiological and Ultrasound Technology
Reference29 articles.
1. Hoshimoto S, Hoshi N, Hishinuma S, et al. Clinical implications of the proliferative ability of the squamous component regarding tumor progression of adenosquamous carcinoma of the pancreas: A preliminary report. Pancreatology. 2017; 17(5):788-94.
2. Zhao X, Li H, Lyu S, et al. Single-cell transcriptomics reveals heterogeneous progression and EGFR activation in pancreatic adenosquamous carcinoma. Int J Biol Sci. 2021; 17(10):2590-605.
3. Boyd CA, Benarroch-Gampel J, Sheffield KM, Cooksley CD, Riall TS. 415 patients with adenosquamous carcinoma of the pancreas: a population-based analysis of prognosis and survival. J Surg Res. 2012; 174(1):12-9.
4. Wild AT, Dholakia AS, Fan KY, et al. Efficacy of platinum chemotherapy agents in the adjuvant setting for adenosquamous carcinoma of the pancreas. J Gastrointest Oncol. 2015; 6(2):115-25.
5. De Souza AL, Saif MW. Platinum-based therapy in adenosquamous pancreatic cancer: experience at two institutions. Jop. 2014; 15(2):144-6.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献